Australia markets close in 25 minutes

4D pharma plc (LBPS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.17+0.24 (+3.46%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
534
534
211
0
0
Operating expenses
Research development
22,041
22,041
26,512
24,908
16,911
Selling general and administrative
4,096
4,096
1,572
2,239
2,128
Total operating expenses
31,075
31,075
30,825
29,119
20,361
Operating income or loss
-30,541
-30,541
-30,614
-29,119
-20,361
Interest expense
173
173
514
348
123
Income before tax
-30,346
-30,346
-29,426
-28,437
-23,986
Income tax expense
-4,383
-4,383
-5,360
-4,747
-3,541
Income from continuing operations
-25,963
-25,963
-24,066
-23,690
-20,445
Net income
-25,963
-25,963
-24,066
-23,690
-20,445
Net income available to common shareholders
-25,963
-25,963
-24,066
-23,690
-20,445
Basic EPS
-
-
-2.94
-2.89
-2.51
Diluted EPS
-
-
-2.94
-2.89
-2.51
Basic average shares
-
-
8,187
8,187
8,136
Diluted average shares
-
-
8,187
8,187
8,136
EBITDA
-
-28,967
-27,631
-26,888
-22,881